Role of Fibrin Sealants in Surgical Procedures on Patients With Hemostatic Disorders
- 1 July 1996
- journal article
- review article
- Published by Wolters Kluwer Health
- Vol. 328 (328), 65-75
- https://doi.org/10.1097/00003086-199607000-00013
Abstract
Fibrin sealants have until now been used to a very limited extent in patients with a bleeding diathesis. The authors have accumulated experience from 8 minor and 40 major surgical procedures, plus 10 circumcisions and 118 tooth extractions in 106 patients suffering from hemophilia A, B, or von Willebrand's disease. Most of the patients had the severe form of the disease. The authors were able to show a reduction of blood loss and of requirements for replacement therapy with factor concentrates. The literature on the application of fibrin sealants in this group of patients, which mainly deals with dental procedures, is reviewed and compared with data from the current study. The composition of the glue is of major significance and is discussed in detail.Keywords
This publication has 46 references indexed in Scilit:
- Type‐2 plasminogen‐activator inhibitor is a substrate for trophoblast transglutaminase and Factor XIIIaEuropean Journal of Biochemistry, 1993
- Effect of antibiotics in fibrin sealant on healing colonic anastomoses in the ratBritish Journal of Surgery, 1992
- Interactions of factor XIII with fibrin as substrate and cofactorBiochemistry, 1992
- Hemostatic Effect of Tranexamic Acid Mouthwash in Anticoagulant-Treated Patients Undergoing Oral SurgeryNew England Journal of Medicine, 1989
- Vitronectin is a substrate for transglutaminasesBiochemical and Biophysical Research Communications, 1988
- Thrombospondin is a substrate for blood coagulation factor XIIIaBiochemistry, 1986
- Transglutaminase-sensitive glutamine residues of human plasma fibronectin reveled by studying its proteolytic fragmentsEuropean Journal of Biochemistry, 1986
- The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after traumaScandinavian Journal of Clinical and Laboratory Investigation, 1985
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Sequence location of a putative transglutaminase crosslinking site in human α2‐macroglobulinFEBS Letters, 1981